Literature DB >> 7704091

Effect of CL 316,243, a novel beta 3-adrenoceptor agonist, on insulin secretion in perfused mouse pancreas.

T Yoshida1, K Yoshioka, N Hiraoka, T Umekawa, N Sakane, M Kondo.   

Abstract

In order to clarify the insulin-release mechanism of beta 3-adrenoceptor agonist, we examined the effect of CL 316,243, a highly specific beta 3-adrenoceptor agonist having a relative potency of beta 1:beta 2:beta 3 = 0:1:100,000, on insulin secretion in perfused mouse pancreas. The application of 0.2 mM and 0.5 mM CL 316,243 produced significant insulin secretion from within 1 min, which lasted until 2 min after its withdrawal. DL-propranolol and ICI 118551 at 0.2 mM partially inhibited the insulin secretion induced by the 0.2 mM CL 316,243, but 0.2 mM metoprolol had no effect on the insulin release produced by 0.2 mM CL 316,243. We conclude that beta 3-adrenoceptor agonist stimulates insulin secretion via beta 3-action in the perfused mouse pancreas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7704091     DOI: 10.1507/endocrj.41.671

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  3 in total

1.  Combining a β3 adrenergic receptor agonist with alpha-lipoic acid reduces inflammation in male mice with diet-induced obesity.

Authors:  Zahraa Abdul Sater; Cheryl Cero; Anne E Pierce; Hannah J Lea; Houssein Abdul Sater; Kenneth Y Zhu; Naili Liu; Yinyan Ma; Oksana Gavrilova; Aaron M Cypess
Journal:  Obesity (Silver Spring)       Date:  2021-11-25       Impact factor: 9.298

2.  Brown Fat AKT2 Is a Cold-Induced Kinase that Stimulates ChREBP-Mediated De Novo Lipogenesis to Optimize Fuel Storage and Thermogenesis.

Authors:  Joan Sanchez-Gurmaches; Yuefeng Tang; Naja Zenius Jespersen; Martina Wallace; Camila Martinez Calejman; Sharvari Gujja; Huawei Li; Yvonne J K Edwards; Christian Wolfrum; Christian M Metallo; Søren Nielsen; Camilla Scheele; David A Guertin
Journal:  Cell Metab       Date:  2017-11-16       Impact factor: 27.287

3.  The glucose lowering effects of CL 316,243 dissipate with repeated use and are rescued bycilostamide.

Authors:  Kyle D Medak; Greg L McKie; Hesham Shamshoum; Ian Seguin; David C Wright
Journal:  Physiol Rep       Date:  2022-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.